关注
Kenji Miyazawa
Kenji Miyazawa
Moderna Therapeutics
在 modernatx.com 的电子邮件经过验证
标题
引用次数
引用次数
年份
Trauma‐targeted delivery of tranexamic acid improves hemostasis and survival in rat liver hemorrhage model
A Girish, DSA Hickman, A Banerjee, N Luc, Y Ma, K Miyazawa, ...
Journal of Thrombosis and Haemostasis 17 (10), 1632-1644, 2019
362019
Combination targeting of ‘platelets+ fibrin’enhances clot anchorage efficiency of nanoparticles for vascular drug delivery
M Sun, K Miyazawa, T Pendekanti, A Razmi, E Firlar, S Yang, T Shokuhfar, ...
Nanoscale 12 (41), 21255-21270, 2020
232020
Inhibition of platelet-surface-bound proteins during coagulation under flow I: TFPI
K Miyazawa, AL Fogelson, K Leiderman
Biophysical journal 122 (1), 99-113, 2023
142023
Development of a minimal PBPK-QSP modeling platform for LNP-mRNA based therapeutics to study tissue disposition and protein expression dynamics
K Miyazawa, Y Liu, H Bazzazi
Frontiers in Nanotechnology 6, 1330406, 2024
52024
Examining downstream effects of concizumab in hemophilia A with a mathematical modeling approach
K Miyazawa, AE Mast, AR Wufsus, M Dockal, M Kjalke, K Leiderman
Journal of Thrombosis and Haemostasis, 2024
2024
OC 59.2 Analyzing Concizumab Mechanism of Action by a Mathematical Modeling Approach
K Miyazawa, A Mast, M Dockal, M Kjalke, K Leiderman
Research and Practice in Thrombosis and Haemostasis 7, 2023
2023
Mathematical Model of Coagulation Under Flow: Understanding the Role of Cell Surfaces for Inhibition and a Clinical Application
K Miyazawa
Colorado School of Mines, 2023
2023
系统目前无法执行此操作,请稍后再试。
文章 1–7